APA (7th ed.) Citation

Wei-Hao Hsu, Wei-Hao Hsu, Shu-Ping Sue, Shu-Ping Sue, Hsiu-Ling Liang, Hsiu-Ling Liang, . . . Mei-Yueh Lee. (2021). Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Wei-Hao Hsu, et al. Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Wei-Hao Hsu, et al. Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan. Frontiers Media S.A., 2021.